Co-crystal production method
    4.
    发明授权

    公开(公告)号:US09635856B2

    公开(公告)日:2017-05-02

    申请号:US15103925

    申请日:2014-12-10

    发明人: Satoru Yamamura

    摘要: The present invention provides a method for producing a co-crystal including thiophanate-methyl and a triazole-based compound such as tebuconazole and a method for producing an agricultural and horticultural chemical preparation using the co-crystal as a raw material. As one example, the agricultural and horticultural chemical preparation can be obtained by a method including the steps of obtaining a sol including a co-crystal by stirring a suspension including thiophanate-methyl, a triazole compound such as a tebuconazole, a surfactant, a defoaming agent and water at a mixing degree of 0.1-1.0 while holding the temperature of the suspension at 60° C.; and adding auxiliary components such as silica, calcium carbonate and the like to the sol.

    Cdc42 Inhibitor and Uses Thereof
    6.
    发明申请
    Cdc42 Inhibitor and Uses Thereof 审中-公开
    Cdc42抑制剂及其用途

    公开(公告)号:US20140194451A1

    公开(公告)日:2014-07-10

    申请号:US14087662

    申请日:2013-11-22

    IPC分类号: C07D239/42 C07C335/12

    摘要: Compounds which inhibit the small G protein Rho GTPase cell division cycle protein Cdc42 are provided. Morphological analyses of filopodia, western blots of Ccd42 phosphorylation, and effects on cellular wound healing and on growth cone formation all demonstrate that the described compounds are able to inhibit all tested Cdc42-mediated processes. The compounds effectively inhibit, the effects of Cdc42 and effectively inhibit Cdc42-related cellular functions involving actin, such as Golgi organization and cell movement. Furthermore, the described Cdc42 inhibitor compounds may be provided as a medicament for the treatment of various conditions.

    摘要翻译: 提供抑制小G蛋白Rho GTPase细胞分裂周期蛋白Cdc42的化合物。 丝状伪足,Ccd42磷酸化的蛋白质印迹以及对细胞伤口愈合和对生长锥形成的影响的形态学分析都证明所述化合物能够抑制所有测试的Cdc42介导的过程。 这些化合物有效抑制Cdc42的作用,并有效抑制涉及肌动蛋白的Cdc42相关细胞功能,如高尔基体组织和细胞运动。 此外,所述Cdc42抑制剂化合物可以作为治疗各种病症的药物提供。